{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:00:45Z","timestamp":1760266845788},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T00:00:00Z","timestamp":1205193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s10067-008-0857-5","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T08:57:06Z","timestamp":1205139426000},"page":"933-936","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy of etanercept in the treatment of a patient with Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"27","author":[{"given":"Valentina","family":"Curigliano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Giovinale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Fonnesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cerquaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Verrecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Turco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,11]]},"reference":[{"key":"857_CR1","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/00003495-200767140-00004","volume":"67","author":"A Gul","year":"2007","unstructured":"Gul A (2007) Standard and novel therapeutic approaches to Beh\u00e7et\u2019s disease. Drugs 67:2013\u20132022","journal-title":"Drugs"},{"key":"857_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","volume":"4","author":"M Suzuki Kurokawa","year":"2004","unstructured":"Suzuki Kurokawa M, Suzuki N (2004) Behcet\u2019s disease. Clin Exp Med 4:10\u201320","journal-title":"Clin Exp Med"},{"issue":"Suppl 2","key":"857_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.61.suppl_2.ii51","volume":"61","author":"PP Sfikasis","year":"2002","unstructured":"Sfikasis PP (2002) Beh\u00e7et\u2019s disease: a new target for anti-tumor necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):51\u201353","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"857_CR4","first-page":"3","volume":"11","author":"Ka Papp","year":"2007","unstructured":"Papp Ka, Keystone EC, Shear NH (2007) Mechanism of action, pharmacolokinetic and drug interection of Etanercept. Dermatology 11(Suppl 1):3\u201313","journal-title":"Dermatology"},{"key":"857_CR5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","volume":"301","author":"B Scallon","year":"2002","unstructured":"Scallon B, Cai A, Solowski N et al (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301:418\u2013426","journal-title":"J Pharmacol Exp Ther"},{"key":"857_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.bor.0000197995.27579.9b","volume":"18","author":"N Pipitone","year":"2006","unstructured":"Pipitone N, Olivieri I, Cantini F et al (2006) New approaches in the treatment of Adamantiades-Beh\u00e7et\u2019s disease. Curr Opin Rheumatol 18:3\u20139","journal-title":"Curr Opin Rheumatol"},{"key":"857_CR7","first-page":"1362","volume":"31","author":"S Ohno","year":"2004","unstructured":"Ohno S, Nakamura S, Hori S et al (2004) Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et\u2019s disease with refractory uveoretinitis. J Rheumatol 31:1362\u20131368","journal-title":"J Rheumatol"},{"key":"857_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0009-9236(02)17635-1","volume":"73","author":"H Lee","year":"2003","unstructured":"Lee H, Kimko HC, Rogge M et al (2003) Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clin Pharmacol Ther 73:348\u2013365","journal-title":"Clin Pharmacol Ther"},{"key":"857_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1345\/aph.19126","volume":"34","author":"JM Korth-Bradley","year":"2003","unstructured":"Korth-Bradley JM, Rubin AS, Hanna RK et al (2003) The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother 34:161\u2013164","journal-title":"Ann Pharmacother"},{"key":"857_CR10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0091270004273321","volume":"45","author":"H Zhou","year":"2005","unstructured":"Zhou H (2005) Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein. J Clin Pharmacol 45:490\u2013497","journal-title":"J Clin Pharmacol"},{"key":"857_CR11","first-page":"98","volume":"32","author":"M Melikoglu","year":"2005","unstructured":"Melikoglu M, Fresko I, Mat C et al (2005) Short-term trial of etanercept in Beh\u00e7et\u2019s disease: a double blind, placebo controlled study. J Rheumatol 32:98\u2013105","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0857-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-008-0857-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0857-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:12Z","timestamp":1559119872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-0857-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,11]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-0857-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,11]]}}}